My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for hepatic drug delivery in aging. https://t.co/zbF54W89lU @CeraUsyd
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2021 – Dec 2021Where it's discussed
-
X / Twitter17 posts
-
YouTube2 videos
AI synopsis
What people are saying
The discussions underscore the groundbreaking nature of the quantum dot formulations, with commenters praising the advancements in drug delivery and bioavailability improvements, such as 'Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties.' The tone is enthusiastic and optimistic, reflecting high interest and perceived impact on medicine and aging-related treatments.
Most discussions praise the significance and advancement of nanomedicine, evident from phrases like 'Congratulations' and 'Great work,' indicating strong agreement with the publication's contributions.
The discussions demonstrate high curiosity and enthusiasm, especially highlighting the innovative aspects of quantum dot formulations and their potential applications.
Users show deep engagement through references to specific research details, such as improved bioavailability, altered uptake pathways, and possible applications in age-related diseases.
There is a consensus that this research has high potential to impact medical treatments, emphasized by terms like 'dramatically improve' and mentions of implications for neurodegenerative and oncological diseases.
Abstract in brief
- Orally administered AgS quantum dots (QDs) enhance the delivery and efficacy of metformin and NMN by improving bioavailability and liver targeting in both young and old mice.
- QD-conjugated drugs show significantly greater potency compared to their unconjugated counterparts, improving glucose tolerance and metabolic response, especially in older mice.
- After 100 days of treatment, QDs demonstrate safety with no signs of cellular damage, proving their potential as effective nanomedicine carriers in combating metabolic issues related to aging.
Top posts
Most liked on X and BlueskyCongratulations @sydneynano members @ProfZdenka @wchrzanowski, Christina Limantoro and Nick Hunt on recent publication - "Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways ... " DOI: 10.1021/acsnano.0c09278
These quantum dots are really something amazing! Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of … https://t.co/dgz4gQBHnN
Great work by Nick Hunt and colleagues at the ANZAC Research Institute:https://t.co/uUqCpenlR0
RT @NicholasJHunt1: My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for h…
All mentions
Enhanced Delivery of NMN and Metformin Using Quantum Dot Nanomedicine
This video reviews a study on quantum dots improving NMN and metformin delivery, increasing bioavailability and efficacy in mice. Quantum dot-conjugated drugs show greater potency and safety in treating age-related…
Nanotech-Driven Targeted Liver Drug Delivery for Metabolic Health
Targeted hepatic drug delivery using nanotechnology for metabolic and age-associated conditions. Ag2S quantum dots enhance bioavailability of metformin and NMN, improving metabolic response and safety in young and old…
RT @SydneyNano:
RT @SydneyNano: Congratulations @sydneynano members @ProfZdenka @wchrzanowski, Christina Limantoro and Nick Hunt on recent publication - "Q…
RT @SydneyNano: Congratulations @sydneynano members @ProfZdenka @wchrzanowski, Christina Limantoro and Nick Hunt on recent publication - "Q…
RT @SydneyNano: Congratulations @sydneynano members @ProfZdenka @wchrzanowski, Christina Limantoro and Nick Hunt on recent publication - "Q…
Congratulations @sydneynano members @ProfZdenka @wchrzanowski, Christina Limantoro and Nick Hunt on recent publication - "Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways ... " DOI: 10.1021/acsnano.0c09278
RT @NicholasJHunt1: My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for h…
RT @NicholasJHunt1: My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for h…
RT @NicholasJHunt1: My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for h…
RT @NicholasJHunt1: My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for h…
My @SydneyNano Meet the Author talk is now on Youtube. We discuss how our @acsnano paper examining nanotechnology for hepatic drug delivery in aging. https://t.co/zbF54W89lU @CeraUsyd
RT @CeraUsyd: These quantum dots are really something amazing! Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological…
Great work by Nick Hunt and colleagues at the ANZAC Research Institute:https://t.co/uUqCpenlR0
RT @CeraUsyd: These quantum dots are really something amazing! Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological…
These quantum dots are really something amazing! Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of … https://t.co/dgz4gQBHnN
New article: Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of Metformin and Nicotinamide Mononucleotide in Aging Mice https://t.co/orAksQ9BR2 #alzheimers #neurology https://t.co/TLqYpU3BWf
New article: Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of Metformin and Nicotinamide Mononucleotide in Aging Mice https://t.co/ueUiaCakkJ #livercancer #oncology https://t.co/51QdHetefS